Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 261-272

  Johnson, James R ^a,b   Stell, Adam L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; ESCHERICHIA COLI; FIMBRIA; HUMAN; PATHOGENICITY; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

BACTEREMIA; DNA PRIMERS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; GENOTYPE; HUMANS; PHYLOGENY; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS; VIRULENCE; WASHINGTON;

EID: 0033963533     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315217     Document Type: Article

References (88)

1. 1. Eisenstein BI, Jones GW. The spectrum of infections and pathogenic mechanisms of Escherichia coli. Adv Intern Med 1988;33:231-52.
2. 2. Orskov I, Orskov F. Escherichia coli in extra-intestinal infections. J Hyg (Lond) 1985;95:551-75.
3. 3. Lipsky BJ. Urinary tract infections in men: epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med 1989;110:138-50.
4. 4. Sussman M. Escherichia coli and human disease. In: Sussman M. Escherichia coli: mechanisms of virulence. Cambridge. UK: Cambridge University Press, 1997:3-48.
5. 5. Selander RK, Caugant DA, Whittam TS. Genetic structure and variation in natural populations of Escherichia coli. In: Neidhardt FC, Ingraham KL, Magasanik B, Low KB, Schaechter M, Umbarger HE. Escherichia coli and Salmonella typhimurium: cellular and molecular biology. Washington, DC: American Society for Microbiology, 1987:1625-48.
6. 6. Bettelheim KA. Escherichia coli in the normal flora of humans and animals. In: Sussman M. Escherichia coli: mechanisms of virulence. Cambridge, UK: Cambridge University Press, 1997:85-109.
7. 7. Herzer PJ, Inouye S, Inouye M, Whittam TS. Phylogenetic distribution of branched RNS-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 1990;172:6175-81.
8. 8. Picard B, Sevali Garcia J. Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999;67:546-53.
9. 9. Selander RK, Korhonen TK, Väisänen-Rhen V, Williams PH, Pattison PE, Caugant DA. Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis. Infect Immun 1986;52:213-22.
10. 10. Bingen K, Picard B, Brahimi N, et al. Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis 1998;177:642-50.
11. 11. Lecointre G, Rachdi L, Darlu P, Denamur E. Escherichia coli molecular phylogeny using the incongruence length difference test. Mol Biol Evol 1998;15:1685-95.
12. 12. Vaisanen-Rhen V, Elo J, Vaisanen E, et al. P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun 1984;43:149-55.
13. 13. Orskov I, Orskov F, Birch-Andersen A, Kanamori M, Svanborg Eden C. O, K. H and fimbrial antigens in Escherichia coli serotypes associated with pyelonephritis and cystitis. Scand J Infect Dis 1982;33(Suppl):18-25.
14. 14. Orskov F, Orskov I. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the enterobacteriaciae and other bacteria. J Infect Dis 1983;148:346-57.
15. 15. Maslow JN, Whittam TS, Gilks CF, et al. Clonal relationships among bloodstream isolates of Escherichia coli. Infect Immun 1995;63:2409-17.
16. 16. Achtman M. Clonal analysis of descent and virulence among selected Escherichia coli. Annu Rev Microbiol 1986;40:185-210.
17. 17. Korhonen TK, Valtonen MV, Parkkinen J, et al. Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun 1985;48:486-91.
18. 18. Achtman M, Mercer A, Kusecek B, et al. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect Immun 1983;39:315-35.
19. 19. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991;4:80-128.
20. 20. Donnenberg MS, Welch RA, Virulence determinants of uropathogenic Escherichia coli. In: Mobley HLT, Warren JW. Urinary tract infections: molecular pathogenesis and clinical management. Washington, DC: ASM Press, 1996: 135-74.
21. 21. Boyd EF, Hartl DL. Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution. J Bacteriol 1998;180:1159-65.
22. 22. Russo TA, Wenderoth S, Carlino UB, Merrick JM, Lesse AJ. Identification, genomic organization, and analysis of the group III capsular polysaccharide genes kpsD, kpsM, kpsT and kpsE from an extraintestinal isolate of Escherichia coli (CP9, O4/K54/H5). J Bacteriol 1998;180:338-49.
23. 23. Huang S-H, Wass C, Fu Q, Prasadarao NV, Stins M, Kim KS. Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10. Infect Immun 1995;63:4470-5.
24. 24. Langermann S, Palaszynski S, Barnhart M, et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997;276:607-11.
25. 25. Johnson JR, Stamm WE. Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 1989;111:906-17.
26. 26. Johnson JR. Epidemiological considerations in studies of adherence. In: Doyle RJ, Ofek I. Adhesion of microbial pathogens: methods in enzymology. Vol 253. Orlando, FL: Academic Press, 1995;167-78.
27. 27. Johnson JR, Moseley S, Roberts P, Stamm WE. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988;56:405-12.
28. 28. Johnson JR, Orskov I, Orskov F, et al. O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli strains causing urosepsis. J Infect Dis 1994;169:119-26.
29. 29. Johnson JR, Goullet PH, Picard B, Moseley SL, Roberts PL, Stamm WE. Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli causing urosepsis. Infect Immun 1991;59:2311-5.
30. 30. Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994;62:244-51.
31. 31. Peres SY, Marches O, Daigle F, et al. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 1997;24:1095-107.
32. 32. Russo TA, Jodush ST, Brown JJ, Johnson JR. Identification of two previously unrecognized genes (guaA, orgC) important for uropathogenesis. Mol Microbiol 1996;22:217-29.
33. 33. Russo TA, Carlino UB, Mong A, Jodush ST. Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine. Infect Immun 1999;67:5306-14.
34. 34. Schubert S, Rakin A, Karch H, Carniel E, Heesemann J. Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun 1998;66:480-5.
35. 35. Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog 1988;4:103-13.
36. 36. Zhang L, Foxman B, Tallman P, Cladera E, Le Bougenec C, Marrs CF. Distribution of drb genes coding for Dr binding adhesins among uropathogenic and fecal Escherichia coli isolates and identification of new subtypes. Infect Immun 1997;65:2011-8.
37. 37. Island MD, Cui X, Warren JW. Effect of Escherichia coli cytotoxic necrotizing factor I on repair of human bladder cell monolayers in vitro. Infect Immun 1999;67:3657-61.
38. 38. Sokurenko EV, Chesnokova V, Dykhuizen DE, et al. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci USA 1998;95:8922-6.
39. 39. Johnson JR, Russo TA, Brown JJ, Stapleton A. papG alleles of Escherichia coli strains causing first episode or recurrent acute cystitis in adult women. J Infect Dis 1998;177:97-101.
40. 40. Johnson JR, Brown JJ, Maslow JN. Clonal distribution of the three alleles of the Gal(al-4)Gal-specific adhesin gene papG among Escherichia coli strains from patients with bacteremia. J Infect Dis 1998;177:651-61.
41. 41. Johnson JR. papG alleles among Escherichia coli strains causing urosepsis: associations with other bacterial characteristics and host compromise. Infect Immun 1998;66:4568-71.
42. 42. Connell H, Agace W, Klemm P, Schembri M, Marild S. Svanborg C. Type I fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci USA 1996;93:9827-32.
43. 43. Saren A. Virkola R, Hacker J, Korhonen TK. The cellular form of human fibronectin as an adhesion target for the S fimbriae of meningitis-associated Escherichia coli. Infect Immun 1999;67:2671-6.
44. 44. van Die I, Kramer C, Hacker J, Bergmans H, Jongen W, Hoekstra W. Nucleotide sequence of the genes coding for minor fimbrial subunits of the F1C fimbriae of Escherichia coli. Res Microbiol 1991;142:653-8.
45. 45. Gleason TG, Houlgrave CW, May AK, et al. Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1b (1L-1b) but augments the lethality of Escherichia coli by an IL-1 and tumor necrosis factor-independent mechanism. Infect Immun 1998;66:4215-21.
46. 46. Groisman EA, Ochman H. Pathogenicity islands: Bacterial evolution in quantum leaps. Cell 1996;87:791-4.
47. 47. High NJ, Hales BA, Jann K, Boulnois GJ. A block of urovirulence genes encoding multiple fimbriae and hemolysin in Escherichia coli O4:K12:H Infect Immun 1988;56:513-7.
48. 48. Ritter A, Blum G, Emody L, et al. tRNA genes and pathogenicity islands: influence on virulence and metabolic properties of uropathogenic Escherichia coli. Mol Microbiol 1995;17:109-21.
49. 49. Low D, David V, Lark D, Schoolnik G, Falkow S. Gene clusters governing the production of hemolysin and mannose-resistant hemagglutination are closely linked in Escherichia coli serotype O4 and O6 isolates from urinary tract infection. Infect Immun 1984;43:353-8.
50. 50. Guyer DM, Kao J-S, Mobley HLT. Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter-associated bacteriuria and from fecal samples. Infect Immun 1998;66:4411-7.
51. 51. Kao J, Stucker DM, Warren JW, Mobley HLT. Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains. Infect Immun 1997;65:2812-20.
52. 52. Swenson DL, Bukanov NO, Berg DE, Welch RA. Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing. Infect Immun 1996:64:3736-43.
53. 53. Le Bouguenec C, Archambaud M, Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 1992;30:1189-93.
54. 54. Yamamoto S, Terai A, Yuri K, Kurazono H, Takeda Y, Yoshida O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 1995;12:85-90.
55. 55. Johnson JR, Brown JJ. A novel multiply-primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(al-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis 1996;173:920-6.
56. 56. Mitsumori K, Terai A, Yamamoto S, Yoshida O. Identification of S, F1C and three PapG fimbrial adhesins in uropathogenic Escherichia coli by polymerase chain reaction. FEMS Immunol Med Microbiol 1998;21: 261-8.
57. 57. Johnson JR, Brown JJ. Colonization with and acquisition of uropathogenic Escherichia coli strains as revealed by polymerase chain reaction-based detection. J Infect Dis 1998;177:1120-4.
58. 58. Foxman B, Zhang L, Tallman P, et al. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J Infect Dis 1995;172:1536-41.
59. 59. Blanco M, Blanco JE, Blanco J, et al. Polymerase chain reaction for detection of Escherichia coli strains producing cytotoxic necrotizing factor type 1 and 2 (CNF1 and CNF2). J Microbiol Methods 1996;26:95-101.
60. 60. Marklund BI, Tennent JM, Garcia E, et al. Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol 1992;6: 2225-42.
61. 61. Guth BEC, Giraldi R, Gomes TAT. Marques LRM. Survey of cytotoxin production among Escherichia coli strains characterized as enteropathogenic (EPEC) by serotyping and presence of EPEC adherence factor (EAF) sequences. Can J Microbiol 1994;40:341-4.
62. 62. Pavelka MS Jr, Wright LF, Silver RP. Identification of two genes, kpsM and kpsT, in region 3 of the polysialic acid gene cluster of Escherichia coli K1. J Bacteriol 1991;173:4603-10.
63. 63. Smith AN. Boulnois GJ, Roberts IS. Molecular analysis of the Escherichia coli K5 kps locus: identification and characterization of an inner-membrane capsular polysaccharide transport system. Mol Microbiol 1990;4:1863-9.
64. 64. Lukomski S, Hull RA, Hull SI. Identification of the O antigen polymerase (rfc) gene in Escherichia coli O4 by insertional mutagenesis using a non-polar chloramphenicol resistance cassette. J Bacteriol 1996;178:240-7.
65. J96 ("Class III") Gal(al-4)Gal-binding adhesins. J Infect Dis 1997;175:983-8.
66. 66. Johnson JR, Stapleton AE, Russo TA, Scheutz FS, Brown JJ, Maslow, JN. Characteristics and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the class I and class III alleles of papG. Infect Immun 1997;65:2153-9.
67. 67. Gilson L, Mahanty HK, Kolter R. Four plasmid genes are required for colicin V synthesis, export, and immunity. J Bacteriol 1987;169:2466-70.
68. 68. Kanukollu U. Bieler S. Hull S, Hull R. Contribution of the traT gene to serum resistance among clinical isolates of enterobacteriaciae. J Med Microbiol 1985;19:61-7.
69. 69. Fernandez-Beros ME, Kissel V, Lior H, Cabello FC. Virulence-related genes in ColV plasmids of Escherichia coli isolated from human blood and intestines. J Clin Microbiol 1990;28:742-6.
70. 70. Chuba PJ, Leon MA, Banerjee A, Palchaudhuri S. Cloning and DNA sequence of plasmid determinant iss, coding for increased serum survival and surface exclusion, which has homology with lambda DNA. Mol Gen Genet 1989;216:287-92.
71. 71. Johnson JR, Roberts P, Stamm WE. P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patient's characteristics. J Infect Dis 1987;156:225-9.
72. 72. Desjardins P, Picard B, Kaltenbock B, Elion J, Denamur E. Sex in Escherichia coli does not disrupt the clonal structure of the population: evidence from random amplified polymorphic DNA and restriction-fragment length polymorphism. J Mol Evol 1995;41:440-8.
73. 73. Welch RA, Dellinger EP, Minsheu B, Falkow S. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature 1981;294:665-7.
74. 74. Clegg S. Cloning of genes determining the production of mannose-resistant fimbriae in a uropathogenic strain of Escherichia coli belonging to serogroup O6. Infect Immun 1982;38:739-44.
75. 75. Vaisanen V, Korhonen TK, Jokinen M. Gahmberg CG, Ehnholm C. Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet 1982;1:1192.
76. 76. Saarela S, Westerlund-Wikstron B. Rhen M, Korhonen TK. The GafD Protein of the G (F17) fimbrial complex confers adhesiveness of Escherichia coli to laminin. Infect Immun 1996;64:2857-60.
77. 77. Ahrens R. Ott M, Ritter A, et al. Genetic analysis of the gene cluster encoding nonfimbrial adhesin I from an Escherichia coli uropathogen. Infect Immun 1993;61:2505-12.
78. 78. Wooley RE, Nolan LK, Brown J, Gibbs PS, Bounous DI. Phenotypic expression of recombinant plasmids pKT107 and pHK11 in an avirulent avian Escherichia coli. Avian Dis 1994;38:127-34.
79. 79. Hacker J, Schmidt G, Hughes C, Knapp S, Marget M, Goebel W. Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15: H31 Escherichia coli strain. Infect Immun 1985;47:434-40.
80. 80. de Ree JM, van den Bosch JF. Fimbrial serotypes of Escherichia coli strains isolated from extra-intestinal infections. J Med Microbiol 1989;29:95-9.
81. 81. Klann AG, Hull RA, Hull SI. Sequences of the genes encoding the minor tip components of Pap-3 pili of Escherichia coli. Gene 1992;119:95-100.
82. 82. Hull RA, Gill RE, Hsu P, Minshew BH, Falkow S. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun 1981;33:933-8.
83. 83. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981:112-37.
84. 84. Boyd EF, Hartl DL. Diversifying selection governs sequence polymorphisms in the major adhesin proteins FimA. PapA. and SfaA of Escherichia coli. J Mol Evol 1998;47:258-67.
85. 85. Bijlsma IG, van Dijk L, Kusters JG, Gaastra W. Nucleotide sequences of two fimbrial major subunit genes, pmpA and ucaA, from canine-uropathogenic Proteus mirabilis strains. Microbiol 1995;141:1349-57.
86. 86. Marc D, Dho-Moulin M. Analysis of the fim cluster of an avian O2 strains of Escherichia coli: serogroup-specific sites within fimA and nucleotide sequence of fiml. J Med Microbiol 1996;44:444-52.
87. 87. Ott M, Hoschutzky H, Jann K, Van Die I, Hacker J. Gene clusters for S fimbrial adhesin (sfa) and FIC fimbriae (foc) of Escherichia coli: comparative aspects of structure and function. J Bacteriol 1988;170:3983-90.
88. 88. Caugant DA, Levin BR, Orskov I, Orskov F, Svanborg Eden C, Selander RK. Genetic diversity in relation to serotype in Escherichia coli. Infect Immun 1985:49:407-13.